BBIO

NASD BridgeBio Pharma, Inc.
Oct 3, 2026 · 3:24 AM ET EOD Market Closed

$67.25 ↑ +0.00 (+0.00%) Trading Up from the previous close of $67.25, $1.43 below the day’s high of $68.68

YTD change
-12.08%
vs 20-day SMA
-3.08%
vs 200-day SMA
-8.65%

Price ranges

Previous day
$66.23 $68.68
open $67.00 close $67.25
+$0.25 (+0.37%)
Today
$66.23 $68.68
$67.25
Past week
$64.36 $67.34
from $66.28 now $67.25
+$0.97 (+1.46%)
Past month
$64.36 $76.81
from $76.50 now $67.25
-$9.25 (-12.09%)
This year
$62.50 $93.42
from $76.49 now $67.25
-$9.24 (-12.08%)

Price & Performance

-5.03 (-6.96%) / 6M

$61.78$71.94$82.11$92.27Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 28.0% away from all-time highs of $93.42
  • BBIO is down 12% since the beginning of the year
  • BBIO is up 26% over the past 12 months
  • BBIO is down 12% over the past 1 month
  • 12% of all BBIO investors are betting against BBIO

BBIO reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +27.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.78
Earnings momentum -27.2% Quarterly EPS growth
Quarterly change -27.2%

Valuation

P/E ratio N/A
Enterprise value $15.8B
Beta 0.67

Balance sheet & scale

IncomeN/A
Revenue$713.1M
Cash$720.7M
Debt$3.4M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $13.1B

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.